专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

11. 发明申请

US20080108574A1 MELANOCORTIN RECEPTOR MEDIATED MODULATION OF NEUROGENESIS 审中-公开
标题翻译：梅毒素受体介导的神经发生调节
公开(公告)号：US20080108574A1
公开(公告)日：2008-05-08
申请号：US11862115
申请日：2007-09-26
申请人： Carrolee Barlow , Todd Carter , Andrew Morse , Kai Treuner , Kym Lorrain
发明人： Carrolee Barlow , Todd Carter , Andrew Morse , Kai Treuner , Kym Lorrain
IPC分类号： A61K38/10 , A61K31/4178 , A61K31/428 , A61P25/00 , A61P25/24 , C12N5/06 , C12N5/08 , A61P25/30 , A61P25/18 , A61K31/435 , A61K31/4458
CPC分类号： A61K31/4458 , A61K31/165 , A61K31/428 , A61K31/473 , A61K38/34 , A61K45/06 , A61K2300/00
摘要： The present disclosure describes compositions and methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on use of a melanocortin receptor (MCR) modulating agent, optionally in combination with one or more other neurogenic agents, to stimulate or activate the formation of new nerve cells.
摘要翻译：本公开描述了通过刺激或增加神经发生来治疗中枢和周围神经系统的疾病和病症的组合物和方法。本公开内容包括基于使用黑皮质素受体（MCR）调节剂，任选地与一种或多种其它神经源性试剂组合以刺激或激活新神经细胞的形成的组合物和方法。

12. 发明授权

US07678808B2 5 HT receptor mediated neurogenesis 失效
标题翻译： 5 HT受体介导的神经发生
公开(公告)号：US07678808B2
公开(公告)日：2010-03-16
申请号：US11746008
申请日：2007-05-08
申请人： Carrolee Barlow , Todd Carter , Andrew Morse , Kai Treuner , Kym I. Lorrain
发明人： Carrolee Barlow , Todd Carter , Andrew Morse , Kai Treuner , Kym I. Lorrain
IPC分类号： A61K31/44 , A61K31/395 , A61K31/497 , A61K31/501
CPC分类号： A61K31/135 , A61K31/165 , A61K31/195 , A61K31/40 , A61K31/401 , A61K31/415 , A61K31/435 , A61K31/437 , A61K31/4458 , A61K31/485 , A61K31/505 , A61K31/519 , A61K31/538 , A61K31/55 , A61K31/551 , A61K31/5513 , A61K31/64
摘要： The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on use of a 5HTR agent, optionally in combination with one or more other neurogenic agents, to stimulate or activate the formation of new nerve cells.
摘要翻译：本公开描述了通过刺激或增加神经发生来治疗中枢和周围神经系统的疾病和病症的方法。本公开包括基于使用5TR剂（任选与一种或多种其它神经源性药剂组合）刺激或激活新神经细胞形成的组合物和方法。

13. 发明申请

US20090325949A1 5 HT RECEPTOR MEDIATED NEUROGENESIS 审中-公开
标题翻译： 5 HT受体介导的神经发生
公开(公告)号：US20090325949A1
公开(公告)日：2009-12-31
申请号：US12491958
申请日：2009-06-25
申请人： Carrolee Barlow , Todd Carter , Andrew Morse , Kai Treuner , Kym I. Lorrain
发明人： Carrolee Barlow , Todd Carter , Andrew Morse , Kai Treuner , Kym I. Lorrain
IPC分类号： A61K31/538 , C12N5/02 , A61K31/5375 , A61K31/519 , A61K31/497 , A61K31/439 , A61K31/445 , A61K31/4178 , A61K31/4045 , A61K31/195 , A61K31/165
CPC分类号： A61K31/135 , A61K31/165 , A61K31/195 , A61K31/40 , A61K31/401 , A61K31/415 , A61K31/435 , A61K31/437 , A61K31/4458 , A61K31/485 , A61K31/505 , A61K31/519 , A61K31/538 , A61K31/55 , A61K31/551 , A61K31/5513 , A61K31/64
摘要： The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on use of a 5HTR agent, optionally in combination with one or more other neurogenic agents, to stimulate or activate the formation of new nerve cells.
摘要翻译：本公开描述了通过刺激或增加神经发生来治疗中枢和周围神经系统的疾病和病症的方法。本公开包括基于使用5TR剂（任选与一种或多种其它神经源性药剂组合）刺激或激活新神经细胞形成的组合物和方法。

14. 发明申请

US20080188457A1 Modulation of Neurogenesis with Biguanides and GSK3-beta Agents 审中-公开
标题翻译：用双胍和GSK3-β试剂调节神经发生
公开(公告)号：US20080188457A1
公开(公告)日：2008-08-07
申请号：US12024923
申请日：2008-02-01
申请人： Carrolee Barlow , Todd Carter , Andrew Morse , Kai Treuner , Kym I. Lorrain
发明人： Carrolee Barlow , Todd Carter , Andrew Morse , Kai Treuner , Kym I. Lorrain
IPC分类号： A61K31/55 , A61K31/155 , C12N5/06 , A61P25/00 , A61P25/18 , A61P25/20 , A61P25/36 , A61P25/32
CPC分类号： A61K45/06 , A61K31/155 , A61K31/4355 , A61K31/55 , A61K2300/00
摘要： The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on use of one or more biguanides in combination with one or more GSK3-β agents, to stimulate or activate the formation of new nerve cells.
摘要翻译：本公开描述了通过刺激或增加神经发生来治疗中枢和周围神经系统的疾病和病症的方法。本公开包括基于使用一种或多种双胍与一种或多种GSK3-β试剂组合来刺激或激活新神经细胞形成的组合物和方法。

15. 发明申请

US20070276733A1 Method and system for music information retrieval 审中-公开
标题翻译：音乐信息检索方法与系统
公开(公告)号：US20070276733A1
公开(公告)日：2007-11-29
申请号：US11803675
申请日：2007-05-14
申请人： Frank Geshwind , Todd Carter
发明人： Frank Geshwind , Todd Carter
IPC分类号： G06Q30/00
CPC分类号： G06Q30/02 , G06Q30/0251
摘要： Systems and methods are disclosed for searching or finding music with music, by searching, e.g., for music from a library that has a sound that is similar to a given sound provided as a search query, and to methods and systems for tracking revenue generated by these computer-user interactions, and for promoting music and selling advertising space. These include, inter alia, systems that allow a user to discover unknown music, and systems that allow a user to look for music based directly on queries formed from sounds that the user likes. In some embodiments these queries are comprised of a clip or relatively small segment of a larger media file. A client server system comprising web graphical elements, advertisements and/or other affiliated revenue links, elements in support of the music query and a music player, a database, elements for matching music clips to clips from a library, and elements to present results.
摘要翻译：公开了用于通过搜索例如来自具有与作为搜索查询提供的给定声音相似的声音的库的音乐来搜索或发现音乐的系统和方法，以及用于跟踪由作为搜索查询提供的给定声音的收益的方法和系统这些电脑用户互动，并用于宣传音乐和销售广告空间。这些包括允许用户发现未知音乐的系统以及允许用户直接从用户喜欢的声音形成的查询来查找音乐的系统。在一些实施例中，这些查询由较大的媒体文件的剪辑或相对小的段组成。包括网络图形元素，广告和/或其他附属收入链接的客户端服务器系统，支持音乐查询的元素和音乐播放器，数据库，用于将音乐剪辑与来自库的剪辑进行匹配的元素以及呈现结果的元素。

16. 发明申请

US20060234931A1 Treatment of diseases with kinase inhibitors 审中-公开
标题翻译：用激酶抑制剂治疗疾病
公开(公告)号：US20060234931A1
公开(公告)日：2006-10-19
申请号：US10894877
申请日：2004-07-19
申请人： William Biggs , Todd Carter , Miles Fabian , David Lockhart , Patrick Zarrinkar , Daniel Treiber , Phillip Edeen
发明人： William Biggs , Todd Carter , Miles Fabian , David Lockhart , Patrick Zarrinkar , Daniel Treiber , Phillip Edeen
IPC分类号： A61K38/54
CPC分类号： A61K31/50 , A61K31/44 , A61K31/506 , A61K31/5377 , A61K31/54 , G01N33/573
摘要： The invention is directed to the identification and use of additional targets of BIRB 796, imatinib mesylate, and BAY 43-9006. The new targets of BIRB 796, imatinib mesylate, and BAY 43-9006 can be used to screen for suitable therapeutic compounds. Also, novel therapeutic and prophylactic uses for BIRB 796, imatinib mesylate, and BAY 43-9006 are disclosed herein.
摘要翻译：本发明涉及鉴定和使用BIRB 796，甲磺酸伊马替尼和BAY 43-9006的额外靶标。 BIRB 796，甲磺酸伊马替尼和BAY 43-9006的新靶标可用于筛选合适的治疗化合物。此外，本文公开了BIRB 796，甲磺酸伊马替尼和BAY 43-9006的新型治疗和预防用途。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式